Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
4.855 USD | +4.18% | +0.62% | -3.56% |
Sales 2024 * | 76.38M 6.37B | Sales 2025 * | 52.83M 4.41B | Capitalization | 570M 47.53B |
---|---|---|---|---|---|
Net income 2024 * | -119M -9.93B | Net income 2025 * | -141M -11.76B | EV / Sales 2024 * | 5.35 x |
Net cash position 2024 * | 161M 13.45B | Net cash position 2025 * | 67.89M 5.66B | EV / Sales 2025 * | 9.5 x |
P/E ratio 2024 * |
-4.61
x | P/E ratio 2025 * |
-4.36
x | Employees | 267 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 81.8% |
Latest transcript on Wave Life Sciences Ltd.
1 day | +4.18% | ||
1 week | +0.62% | ||
Current month | -21.07% | ||
1 month | -22.82% | ||
3 months | +8.95% | ||
6 months | -10.31% | ||
Current year | -3.56% |
Managers | Title | Age | Since |
---|---|---|---|
Paul Bolno
CEO | Chief Executive Officer | 50 | 01/13/01 |
Kyle Moran
DFI | Director of Finance/CFO | 54 | 01/14/01 |
Chandra Vargeese
CTO | Chief Tech/Sci/R&D Officer | 63 | 01/14/01 |
Members of the board | Title | Age | Since |
---|---|---|---|
Christian Henry
CHM | Chairman | 56 | 10/16/10 |
Mark Corrigan
BRD | Director/Board Member | 66 | 04/19/04 |
Adrian Rawcliffe
BRD | Director/Board Member | 52 | 01/17/01 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.04% | 0 M€ | 0.00% | - | |
0.02% | 0 M€ | 0.00% | - | |
0.00% | 34 M€ | +2.57% | - |
Date | Price | Change | Volume |
---|---|---|---|
29/24/29 | 4.87 | +4.51% | 235 366 |
26/24/26 | 4.66 | -1.69% | 407,036 |
25/24/25 | 4.74 | -5.39% | 397,715 |
24/24/24 | 5.01 | -1.38% | 430,676 |
23/24/23 | 5.08 | +4.96% | 469,439 |
Delayed Quote Nasdaq, April 29, 2024 at 10:50 pm IST
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-3.56% | 570M | |
-2.44% | 103B | |
+1.70% | 95.28B | |
+1.46% | 22.15B | |
-15.77% | 21.02B | |
-8.58% | 18.15B | |
-38.74% | 16.73B | |
-13.04% | 16.05B | |
+5.27% | 13.68B | |
+34.35% | 12.17B |
- Stock Market
- Equities
- WVE Stock